MADRIGAL PHARMACEUTICALS, INC. Operating Lease, Payments
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Operating Lease, Payments of $1.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-19
- MADRIGAL PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2019-03-31 was $30.00K.
- MADRIGAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2025 was $1.40M, a 27.27% increase from fiscal 2024.
- MADRIGAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2024 was $1.10M, a 0.00% change from fiscal 2023.
- MADRIGAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2023 was $1.10M, a 57.14% increase from fiscal 2022.
- MADRIGAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2022 was $700.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 12 month |
|---|---|---|
| 2025-12-31 | $1.40M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $1.10M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $1.10M 10-K · filed 2026-02-19 | |
| 2022-12-31 | $700.00K 10-K · filed 2024-02-28 | |
| 2019-03-31 | $30.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |